138 related articles for article (PubMed ID: 15923408)
41. Adjuvant therapy for gastric cancer: how negative results can help patients.
Ellenberg SS; Sun W
J Natl Cancer Inst; 2007 Apr; 99(8):580-2. PubMed ID: 17440152
[No Abstract] [Full Text] [Related]
42. [Chemotherapy in the treatment of gastric cancer].
Ahn MJ
Korean J Gastroenterol; 2004 Feb; 43(2):75-81. PubMed ID: 14978363
[TBL] [Abstract][Full Text] [Related]
43. [Recent advance of chemotherapy in gastric cancer].
Terazawa T; Shimada Y
Nihon Rinsho; 2012 Oct; 70(10):1783-9. PubMed ID: 23198562
[TBL] [Abstract][Full Text] [Related]
44. The role of chemotherapy in the management of gastric cancer.
De Vivo R; Pignata S; Palaia R; Parisi V; Daniele B
J Clin Gastroenterol; 2000 Jun; 30(4):364-71. PubMed ID: 10875463
[TBL] [Abstract][Full Text] [Related]
45. Treatment of gastric cancer.
Wils J
Curr Opin Oncol; 1998 Jul; 10(4):357-61. PubMed ID: 9702404
[TBL] [Abstract][Full Text] [Related]
46. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.
Ychou M; Boige V; Pignon JP; Conroy T; Bouché O; Lebreton G; Ducourtieux M; Bedenne L; Fabre JM; Saint-Aubert B; Genève J; Lasser P; Rougier P
J Clin Oncol; 2011 May; 29(13):1715-21. PubMed ID: 21444866
[TBL] [Abstract][Full Text] [Related]
47. [Irinotecan (CPT-11) therapy for advanced gastric cancer].
Sakata Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():386-92. PubMed ID: 11424411
[No Abstract] [Full Text] [Related]
48. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
49. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
50. Etoposide in gastric cancer.
Macdonald JS; Havlin KA
Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.
Panzini I; Gianni L; Fattori PP; Tassinari D; Imola M; Fabbri P; Arcangeli V; Drudi G; Canuti D; Fochessati F; Ravaioli A
Tumori; 2002; 88(1):21-7. PubMed ID: 12004845
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
Bamias A; Cunningham D; Nicolson V; Norman A; Hill M; Nicolson M; O'Brien M; Webb A; Hill A
Br J Cancer; 1995 Mar; 71(3):583-6. PubMed ID: 7880742
[TBL] [Abstract][Full Text] [Related]
53. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
[No Abstract] [Full Text] [Related]
54. Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).
Kang YK; Yook JH; Chang HM; Ryu MH; Yoo C; Zang DY; Lee JL; Kim TW; Yang DH; Jang SJ; Park YS; Lee YJ; Jung HY; Kim JH; Kim BS
Cancer Chemother Pharmacol; 2014 Jan; 73(1):139-49. PubMed ID: 24162381
[TBL] [Abstract][Full Text] [Related]
55. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
[TBL] [Abstract][Full Text] [Related]
56. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study.
Topuz E; Basaran M; Saip P; Aydiner A; Argon A; Sakar B; Tas F; Uygun K; Bugra D; Aykan NF
Am J Clin Oncol; 2002 Dec; 25(6):619-24. PubMed ID: 12478012
[TBL] [Abstract][Full Text] [Related]
59. Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart.
Corn BW; Geva R
Cancer Chemother Pharmacol; 2010 May; 65(6):1005-7. PubMed ID: 20174924
[No Abstract] [Full Text] [Related]
60. [Significance of neoadjuvant chemotherapy for gastric cancer].
Fujii M; Kochi M; Mochizuki F
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2028-32. PubMed ID: 11103233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
